Covered recipient · General Payments record
THOMAS MASTAKOURIS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$5,728.99
- Reported across 317 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $423.71 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $248.64 | 17 |
| Lilly USA, LLC | $43.04 | 2 |
| EISAI INC. | $30.25 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.90 | 1 |
| Acerta Pharma LLC | $22.11 | 1 |
| SCILEX PHARMACEUTICALS INC. | $19.27 | 1 |
| Amgen Inc. | $18.41 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.02 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981103 | CMS |
| ABBVIE INC. | $12.26 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981105 | CMS |
| ABBVIE INC. | $9.13 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981107 | CMS |
| ABBVIE INC. | $2.67 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981109 | CMS |
| ABBVIE INC. | $25.69 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981111 | CMS |
| ABBVIE INC. | $23.58 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981113 | CMS |
| ABBVIE INC. | $11.90 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981115 | CMS |
| ABBVIE INC. | $19.11 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981117 | CMS |
| ABBVIE INC. | $13.22 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981119 | CMS |
| ABBVIE INC. | $9.66 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981121 | CMS |
| ABBVIE INC. | $26.14 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981123 | CMS |
| ABBVIE INC. | $9.12 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981125 | CMS |
| ABBVIE INC. | $8.97 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981127 | CMS |
| ABBVIE INC. | $25.63 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981129 | CMS |
| ABBVIE INC. | $11.97 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981131 | CMS |
| ABBVIE INC. | $8.89 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981133 | CMS |
| ABBVIE INC. | $21.68 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981135 | CMS |
| Amgen Inc. | $18.41 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115908090 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.11 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104276495 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.09 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086228352 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.90 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117889376 | CMS |
| Eisai Inc. | $30.25 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785481 | CMS |
| Lilly USA, LLC | $24.97 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135477302 | CMS |
| Lilly USA, LLC | $18.07 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135456737 | CMS |
| SCILEX PHARMACEUTICALS INC. | $19.27 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136237587 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.